Search research articles
Contact Us
Filters
Showing results (1-10 of 100) with videos related to
Page
of 10
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 11, 2024
Second MEK Inhibitor Shows Promise in Neurofibromatosis Type 1 With Symptomatic Plexiform Neurofibromas Signaling Hope for Other RASopathies
Simon J Cook
Pharmacology & Therapeutics
|
October 31, 2009
De-regulated FGF receptors as therapeutic targets in cancer
Victoria Knights, Simon J Cook
The Journal of Biological Chemistry
|
July 30, 2005
Increased expression of Mcl-1 is required for protection against serum starvation in phosphatase and tensin homologue on chromosome 10 null mouse embryonic fibroblasts, but repression of Bim is favored in human glioblastomas
Mark Austin, Simon J Cook
Current Opinion in Pharmacology
|
June 18, 2005
The search for new targets for cancer chemotherapeutics
Simon J Cook, Michael Wakelam
Nature Reviews. Cancer
|
April 25, 2008
Ca2+ signalling checkpoints in cancer: remodelling Ca2+ for cancer cell proliferation and survival
H Llewelyn Roderick, Simon J Cook
British Journal of Pharmacology
|
May 8, 2013
That which does not kill me makes me stronger; combining ERK1/2 pathway inhibitors and BH3 mimetics to kill tumour cells and prevent acquired resistance
Matthew J Sale, Simon J Cook
Biochimica Et Biophysica Acta
|
January 21, 2014
The role of MAPK signalling pathways in the response to endoplasmic reticulum stress
Nicola J Darling, Simon J Cook
The FEBS Journal
|
January 10, 2018
De-RSKing ERK - regulation of ERK1/2-RSK dissociation by phosphorylation within a disordered motif
Andrew M Kidger, Simon J Cook
The Biochemical Journal
|
March 10, 2007
Nutrient-responsive mTOR signalling grows on Sterile ground
Simon J Cook, Simon J Morley
Biochemical Society Transactions
|
August 12, 2014
Intrinsic and acquired resistance to MEK1/2 inhibitors in cancer
Matthew J Sale, Simon J Cook
Page
of 10
Search research articles
Search
Showing results (1-10 of 100) with videos related to
Sort By:
Page
of 10
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 11, 2024
Second MEK Inhibitor Shows Promise in Neurofibromatosis Type 1 With Symptomatic Plexiform Neurofibromas Signaling Hope for Other RASopathies
Simon J Cook
Pharmacology & Therapeutics
|
October 31, 2009
De-regulated FGF receptors as therapeutic targets in cancer
Victoria Knights, Simon J Cook
The Journal of Biological Chemistry
|
July 30, 2005
Increased expression of Mcl-1 is required for protection against serum starvation in phosphatase and tensin homologue on chromosome 10 null mouse embryonic fibroblasts, but repression of Bim is favored in human glioblastomas
Mark Austin, Simon J Cook
Current Opinion in Pharmacology
|
June 18, 2005
The search for new targets for cancer chemotherapeutics
Simon J Cook, Michael Wakelam
Nature Reviews. Cancer
|
April 25, 2008
Ca2+ signalling checkpoints in cancer: remodelling Ca2+ for cancer cell proliferation and survival
H Llewelyn Roderick, Simon J Cook
British Journal of Pharmacology
|
May 8, 2013
That which does not kill me makes me stronger; combining ERK1/2 pathway inhibitors and BH3 mimetics to kill tumour cells and prevent acquired resistance
Matthew J Sale, Simon J Cook
Biochimica Et Biophysica Acta
|
January 21, 2014
The role of MAPK signalling pathways in the response to endoplasmic reticulum stress
Nicola J Darling, Simon J Cook
The FEBS Journal
|
January 10, 2018
De-RSKing ERK - regulation of ERK1/2-RSK dissociation by phosphorylation within a disordered motif
Andrew M Kidger, Simon J Cook
The Biochemical Journal
|
March 10, 2007
Nutrient-responsive mTOR signalling grows on Sterile ground
Simon J Cook, Simon J Morley
Biochemical Society Transactions
|
August 12, 2014
Intrinsic and acquired resistance to MEK1/2 inhibitors in cancer
Matthew J Sale, Simon J Cook
Page
of 10